BNET Industries
Last Fiscal Year Sales:$37.4M
- Private
- US
Dow Jones Description
Develops and manufactures human-based tissue products for tissue repair and transplantation, focusing primarily on skin, cartilage and cardiovascular products. (Nasdaq: ATIS).
Vice President
William R TolbertNumber of Employees 100
Contact Information
10520 Wateridge Cir
San Diego, California 92121
1 858 452 6095
Peer Companies
NAICS Code Surgical Appliance and Supplies Manufacturing: 339113
News & Analysis
Filter by
advanced tissue sciences inc. - All News and Analysis
Advanced Tissue Sciences Inc Deals & Alliances Report
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c76718) has announced the addition of "Advanced Tissue Sciences Inc - Deals and Alliances Report" to their offering. The Advanced Tissue Sciences Inc Deals & Alliances Report contains the company's contact information, business summary, company details, tables, graphs and listings of the number...
Despite California-Based Advanced Tissue Sciences' Demise, Skin Patches Thrive.
By Terri Somers, The San Diego Union-Tribune Knight Ridder/Tribune Business News Oct. 14--Edward Fletcher missed the drama as it unfolded at Advanced Tissue Sciences, a now-defunct La Jolla company that developed a way to make living-tissue skin patches to treat burns and...
Court Confirms Advanced Tissue Sciences' Plan of Reorganization
Business Editors/Health/Medical Writers BIOWIRE2K SAN DIEGO--BUSINESS WIRE--March 19, 2003 Advanced Tissue Sciences, Inc. (OTC BB: ATISQ) today announced that the United States Bankruptcy Court for the Southern District of California has confirmed the company's Chapter 11 Liquidating Plan of Reorganization. The key provisions of the Plan...
Advanced Tissue Sciences Announces Court Approval for Sale of NouriCel Product Line
Business Editors/Health/Medical Writers BIOWIRE2K SAN DIEGO--BUSINESS WIRE--March 19, 2003 Advanced Tissue Sciences, Inc. (OTC BB: ATISQ) today announced that the United States Bankruptcy Court for the Southern District of California has approved the company's motion under section 363 of the U. S. Bankruptcy Code to allow the...
Advanced Tissue Sciences Announces FDA Approval of Human Collagen for Wrinkle Injections
Business Editors/Health/Medical Writers
Advanced Tissue Sciences Files Plan of Reorganization and Disclosure Statement
Business Editors & Health/Medical Writers BIOWIRE2K SAN DIEGO--BUSINESS WIRE--Feb. 7, 2003 Advanced Tissue Sciences, Inc. (OTC BB: ATISQ) today announced it has filed a proposed Liquidating Plan of Reorganization and accompanying Disclosure Statement with the United States Bankruptcy Court for the Southern District of California. The...
Advanced Tissue Sciences Terminates Biozhem Contract
Business Editors & Health/Medical Writers BIOWIRE2K SAN DIEGO--BUSINESS WIRE--Feb. 3, 2003 Advanced Tissue Sciences, Inc. (OTC BB: ATISQ) today announced that it has terminated its license and supply agreement with Biozhem Cosmeceuticals, Inc. related to NouriCel. The contract, which entitled Biozhem to use NouriCel in skin...
Advanced Tissue Sciences Announces Agreement for Sale of NouriCel Product Line
Business Editors & Health/Medical Writers BIOWIRE2K LA JOLLA, Calif.--BUSINESS WIRE--Jan. 6, 2003 Advanced Tissue Sciences, Inc. (OTC BB: ATISQ) today announced it has entered into an agreement to sell its NouriCelTM product line and related intellectual property to SkinMedica, Inc., subject to the approval of the bankruptcy...
Advanced Tissue Sciences Provides Bankruptcy Update
Business Editors and Health/Medical Writers BIOWIRE2K LA JOLLA, Calif.--BUSINESS WIRE--Dec. 19, 2002 Advanced Tissue Sciences, Inc. (OTC BB: ATISQ) today provided an update on certain changes and its activities under its Chapter 11 reorganization. As of Monday, December 23, 2002 the company's business address will change...
Shareholders Wonder Why Executives Got Loans at Ailing La Jolla, Calif., Firm.
By Don Bauder, The San Diego Union-Tribune Knight Ridder/Tribune Business News Dec. 8--When a long-ailing company goes bankrupt, then decides to liquidate, you can't blame its shareholders for asking why, during lean years, it lent money to its two top executives. ...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| William R Tolbert | Vice President |
| Organization | Position | Status |
|---|---|---|
| Advanced Tissue Sciences, Inc. | Vice President | Current |
| Centocor, Inc. | Vice President | Current |
| Invitron Limited | Vice President | Current |
| Merchant-Taylor International, Inc | Senior Associate | Current |
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes


